全文获取类型
收费全文 | 1670篇 |
免费 | 231篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 84篇 |
妇产科学 | 45篇 |
基础医学 | 230篇 |
口腔科学 | 29篇 |
临床医学 | 224篇 |
内科学 | 272篇 |
皮肤病学 | 16篇 |
神经病学 | 154篇 |
特种医学 | 150篇 |
外科学 | 197篇 |
综合类 | 47篇 |
一般理论 | 4篇 |
预防医学 | 186篇 |
眼科学 | 49篇 |
药学 | 78篇 |
肿瘤学 | 124篇 |
出版年
2021年 | 18篇 |
2020年 | 12篇 |
2019年 | 19篇 |
2018年 | 36篇 |
2017年 | 30篇 |
2016年 | 32篇 |
2015年 | 38篇 |
2014年 | 56篇 |
2013年 | 61篇 |
2012年 | 66篇 |
2011年 | 60篇 |
2010年 | 45篇 |
2009年 | 36篇 |
2008年 | 50篇 |
2007年 | 64篇 |
2006年 | 61篇 |
2005年 | 44篇 |
2004年 | 51篇 |
2003年 | 41篇 |
2002年 | 45篇 |
2001年 | 42篇 |
2000年 | 61篇 |
1999年 | 58篇 |
1998年 | 44篇 |
1997年 | 37篇 |
1996年 | 52篇 |
1995年 | 44篇 |
1994年 | 49篇 |
1993年 | 35篇 |
1992年 | 36篇 |
1991年 | 49篇 |
1990年 | 39篇 |
1989年 | 38篇 |
1988年 | 44篇 |
1987年 | 46篇 |
1986年 | 40篇 |
1985年 | 41篇 |
1984年 | 25篇 |
1983年 | 34篇 |
1982年 | 10篇 |
1981年 | 16篇 |
1980年 | 15篇 |
1979年 | 16篇 |
1978年 | 19篇 |
1977年 | 11篇 |
1976年 | 13篇 |
1975年 | 11篇 |
1974年 | 12篇 |
1970年 | 11篇 |
1969年 | 17篇 |
排序方式: 共有1907条查询结果,搜索用时 15 毫秒
991.
E Chu D Haller T Cartwright C Twelves J Cassidy W Sun M W Saif E McKenna S Lee H-J Schmoll 《British journal of cancer》2014,110(6):1438-1445
Background:
Central venous access devices in fluoropyrimidine therapy are associated with complications; however, reliable data are lacking regarding their natural history, associated complications and infusion pump performance in patients with metastatic colorectal cancer.Methods:
We assessed device placement, use during treatment, associated clinical outcomes and infusion pump perfomance in the NO16966 trial.Results:
Device replacement was more common with FOLFOX-4 (5-fluorouracil (5-FU)+oxaliplatin) than XELOX (capecitabine+oxaliplatin) (14.1% vs 5.1%). Baseline device-associated events and post-baseline removal-/placement-related events occurred more frequently with FOLFOX-4 than XELOX (11.5% vs 2.4% and 8.5% vs 2.1%). Pump malfunctions, primarily infusion accelerations in 16% of patients, occurred within 1.6–4.3% of cycles. Fluoropyrimidine-associated grade 3/4 toxicity was increased in FOLFOX-4-treated patients experiencing a malfunction compared with those who did not (97 out of 155 vs 452 out of 825 patients), predominantly with increased grade 3/4 neutropenia (53.5% vs 39.8%). Febrile neutropenia rates were comparable between patient cohorts±malfunction. Efficacy outcomes were similar in patient cohorts±malfunction.Conclusions:
Central venous access device removal or replacement was common and more frequent in patients receiving FOLFOX-4. Pump malfunctions were also common and were associated with increased rates of grade 3/4 haematological adverse events. Oral fluoropyrimidine-based regimens may be preferable to infusional 5-FU based on these findings. 相似文献992.
993.
994.
Richard B. Birrer Thomas J. Cartwright John R. Denton 《The Physician and sportsmedicine》2013,41(10):94-102
In brief Traumatic Injuries to the ankle vary greatly in severity, from minor contusions to displaced intra-articular fractures. A systematic approach to their evaluation can lead to more accurate diagnoses and help simplify treatment options. Primary care physicians can successfully manage most sports-related ankle trauma, but knowing when to obtain orthopedic consultation is equally important. 相似文献
995.
996.
997.
998.
999.
Ihekweazu CA Dance DA Pebody R George RC Smith MD Waight P Christensen H Cartwright KA Stuart JM;South West Pneumococcus Study Group 《Epidemiology and infection》2008,136(8):1096-1102
Introduction of pneumococcal conjugate and polysaccharide vaccines into the United Kingdom's routine immunization programmes is expected to change the epidemiology of invasive pneumococcal disease (IPD). We have documented the epidemiology of IPD in an English region (South West) with high-quality surveillance data before these programmes were established. We analysed data on isolates of Streptococcus pneumoniae from blood and CSF between 1996 and 2005 from microbiology laboratories in the South West that were reported and/or referred for serotyping to the Health Protection Agency Centre for Infections. The mean annual incidence of IPD increased from 11.2/100 000 in 1996 to 13.6/100 000 in 2005 (P<0.04). After adjusting for annual blood-culture sampling rates in hospitals serving the same catchment populations, an increase in annual incidence of IPD was no longer observed (P=1.0). Variation in overall incidence between laboratories could also be explained by variation in blood culture rates. The proportion of disease caused by serotypes 6B, 9V and 14 decreased significantly (P=0.001, P=0.007, and P=0.027 respectively) whereas that caused by serotype 4, 7F and 1 increased (P=0.001, P=0.003, and P<0.001 respectively) between 2000 and 2005. The level of penicillin non-susceptibility and resistance to erythromycin remained stable (2% and 12% respectively). This study provides an important baseline to assess the impact of changing vaccination programmes on the epidemiology of IPD, thus informing future use of pneumococcal vaccines. 相似文献
1000.